Evoke Pharma Inc (EVOK)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Evoke Pharma Inc (EVOK)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH137453D
  • |
  • Pages: 37
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that focuses on the development of drugs for the treatment of gastrointestinal diseases. The company's lead product candidate EVK-001, which is under clinical development that provides relief from the symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. Evoke Pharma provides therapies for various gastrointestinal disorders such as motility disorder, GERD, constipation, peptic ulcers and irritable bowel syndrome and gastroparesis. It seeks to work in collaboration with other commercial organizations and external consultants to develop novel product candidates. Evoke Pharma is headquartered in Solana Beach, California, the US.

Evoke Pharma Inc (EVOK)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Evoke Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Evoke Pharma Inc, Medical Devices Deals, 2011 to YTD 2017 10

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Evoke Pharma Enters into Partnership with Spaulding Clinical Research 12

Equity Offering 12

Evoke Pharma Raises USD8 Million in Public Offering of Shares 12

Evoke Pharma to Raise USD10 Million in Registered Direct Offering 13

Evoke Pharma to Raise USD4.5 Million in Registered Direct Offering 15

Evoke Pharma Raises USD5 Million in Public Offering of Shares 16

Evoke Pharma to Raise Funds through Public Offering of Shares 17

Evoke Pharma Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$29 Million 18

Evoke Pharma Inc-Key Competitors 20

Key Employees 21

Locations And Subsidiaries 22

Head Office 22

Recent Developments 23

Financial Announcements 23

Mar 15, 2017: Evoke Pharma Reports Fourth Quarter and Full Year 2016 Results 23

Nov 09, 2016: Evoke Pharma Reports Third Quarter 2016 Results 24

Aug 15, 2016: Evoke Pharma Reports Second Quarter 2016 Results 25

May 11, 2016: Evoke Pharma Reports First Quarter 2016 Results 26

Mar 10, 2016: Evoke Pharma Reports Fourth Quarter and Year End 2015 Results 27

Product News 28

07/26/2016: Evoke Pharma Receives Conditional FDA Acceptance of Proposed Brand Name for EVK-001 28

05/24/2016: Evoke Pharma Presents Data from Successful Thorough ECG (TQT) Study of EVK-001 at Digestive Disease Week 2016 29

Product Approvals 30

Mar 03, 2016: Evoke Accelerates New Drug Application Process by Engaging Regulatory Experts 30

Clinical Trials 31

Jul 18, 2016: Evoke Pharma Reports Topline Results from EVK-001 Phase 3 Clinical Trial 31

Jun 01, 2016: Evoke Completes Phase 3 Clinical Trial of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis 32

May 03, 2016: Evoke Announces Timing of Phase 3 Results from its Recently Fully Enrolled Pivotal Clinical Trial of EVK-001 33

Apr 25, 2016: Evoke Successfully Completes Phase 3 Clinical Trial Enrollment of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis 34

Mar 01, 2016: Evoke Nears Completion of Phase 3 Clinical Trial Enrollment and Secures Extension to Credit Facility 35

Feb 17, 2016: Evoke Pharma to Present Results From Successful Thorough ECG (TQT) Study of EVK-001 at Digestive Disease Week 2016 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37

List of Figures

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Evoke Pharma Inc, Medical Devices Deals, 2011 to YTD 2017 10

List of Tables

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Evoke Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Evoke Pharma Inc, Deals By Therapy Area, 2011 to YTD 2017 9

Evoke Pharma Inc, Medical Devices Deals, 2011 to YTD 2017 10

Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Evoke Pharma Enters into Partnership with Spaulding Clinical Research 12

Evoke Pharma Raises USD8 Million in Public Offering of Shares 12

Evoke Pharma to Raise USD10 Million in Registered Direct Offering 13

Evoke Pharma to Raise USD4.5 Million in Registered Direct Offering 15

Evoke Pharma Raises USD5 Million in Public Offering of Shares 16

Evoke Pharma to Raise Funds through Public Offering of Shares 17

Evoke Pharma Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$29 Million 18

Evoke Pharma Inc, Key Competitors 20

Evoke Pharma Inc, Key Employees 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Evoke Pharma Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16145
Site License
USD 500 INR 32290
Corporate User License
USD 750 INR 48435

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com